Patnaik, Amita <br/><br/>
Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Oct 2015 
 - 4286-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-14-2607  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Drug Monitoring<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Neoplasm Staging<br/>Neoplasms--drug therapy<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Treatment Outcome